JPRN-UMIN000015105已完成2 期
A randomized phase 2 trial which investigate the most effective administration method of antithrombin (AT) products in patients with disseminated intravascular coagulation (DIC) associated with sepsis during treatment for advanced pancreatic and biliary cancer. - A randomized phase 2 trial of AT-III products in infectious DIC.
Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology0 个研究点目标入组 40 人开始时间: 2014年9月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •pregnat or possible pregnat women
研究者
相似试验
已完成
2 期
Phase II randomized clinical trial to investigate efficacy of zoledronic acid for the patients with metastatic or advanced breast cancerMetastatic breast cancerJPRN-UMIN000027382Kyushu Breast Cancer Study Group (KBC-SG)90
暂停
2 期
A phase II randomized clinical trial to determine the effectiveness of goreisan and saireito for lower limb lymphedema in women treated for gynecologic cancerower Limb LymphedemaLymphedemaD008209JPRN-jRCT1041190019Kajiyama Hiroaki40
进行中（未招募）
1 期
A trial examining the effects of alteplase in patients with severe respiratory failure.EUCTR2010-024377-40-ATMedizinische Universität Wien, UniKlinik für Klinische Pharmakologie
已完成
2 期
Efficacy of a new COVID-19 treatmentPACTR202006899597082Malagasy government60
进行中（未招募）
1 期
Evaluating the effect of Loratadine associated with Rapamune in Lymphagioleiomyomatosis (LAM).EFFECT OF LORATADINE ON LYMPHANGIOLEIOMYOMATOSISMedDRA version: 21.0Level: PTClassification code 10049459Term: LymphangioleiomyomatosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-000702-29-ESIDIBELL (Institut d’Investigació Biomédica de Bellvitge)62